Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Christopher J. Recklitis, Ph.D., MPH is Director of Research and Support Services for the Perini Family Survivors Center at Dana-Farber, and Associate Professor of Pediatrics at Harvard Medical School. He completed doctoral degree in clinical psychology at Boston University, and his Masters in Public Health at the Harvard School of Public Health. Dr. Recklitis's research is focused on understanding the psychological late-effects of cancer, the development of effective screening measures for detecting distress, and the best methods for encouraging health protective behaviors in cancer survivors. He is the Principal Investigator of Project REACH, a longitudinal study of health outcomes in several hundred locally treated cancer survivors. His work has been supported by grants from the National Cancer Institute, Lance Armstrong Foundation, American Foundation for the Prevention of Suicide, and the Childhood Brain Tumor Foundation.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions